Cargando…

The subtle nuances of intranasal corticosteroids

BACKGROUND: In the specialty of Otolaryngology – Head and Neck Surgery, intranasal corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity. All too often, physician prescribing patterns are based on previous training, personal experience, and interactions with i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fowler, James, Rotenberg, Brian W., Sowerby, Leigh J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968222/
https://www.ncbi.nlm.nih.gov/pubmed/33731223
http://dx.doi.org/10.1186/s40463-020-00480-z
_version_ 1783666019906093056
author Fowler, James
Rotenberg, Brian W.
Sowerby, Leigh J.
author_facet Fowler, James
Rotenberg, Brian W.
Sowerby, Leigh J.
author_sort Fowler, James
collection PubMed
description BACKGROUND: In the specialty of Otolaryngology – Head and Neck Surgery, intranasal corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity. All too often, physician prescribing patterns are based on previous training, personal experience, and interactions with industry. The purpose of this commentary is to review the nuances of each intranasal corticosteroid. COMMENTARY: There are nine intranasal corticosteroids approved for use in Canada. Each are discussed in detail, including their indication, bioavailability, effects on intranasal environment, and factors around patient adherence. Off-label use of budesonide irrigations is also discussed and cost information is presented in reference format for all available intranasal corticosteroids. CONCLUSION: Although the efficacy of each intranasal corticosteroid has been shown to be similar, prescribing should be tailored based on bioavailability, intranasal environment, and factors that impact patient adherence such as dosing, cost and tolerability. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-7968222
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79682222021-03-22 The subtle nuances of intranasal corticosteroids Fowler, James Rotenberg, Brian W. Sowerby, Leigh J. J Otolaryngol Head Neck Surg Commentary BACKGROUND: In the specialty of Otolaryngology – Head and Neck Surgery, intranasal corticosteroids are the mainstay treatment for inflammatory processes within the nasal cavity. All too often, physician prescribing patterns are based on previous training, personal experience, and interactions with industry. The purpose of this commentary is to review the nuances of each intranasal corticosteroid. COMMENTARY: There are nine intranasal corticosteroids approved for use in Canada. Each are discussed in detail, including their indication, bioavailability, effects on intranasal environment, and factors around patient adherence. Off-label use of budesonide irrigations is also discussed and cost information is presented in reference format for all available intranasal corticosteroids. CONCLUSION: Although the efficacy of each intranasal corticosteroid has been shown to be similar, prescribing should be tailored based on bioavailability, intranasal environment, and factors that impact patient adherence such as dosing, cost and tolerability. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2021-03-17 /pmc/articles/PMC7968222/ /pubmed/33731223 http://dx.doi.org/10.1186/s40463-020-00480-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Fowler, James
Rotenberg, Brian W.
Sowerby, Leigh J.
The subtle nuances of intranasal corticosteroids
title The subtle nuances of intranasal corticosteroids
title_full The subtle nuances of intranasal corticosteroids
title_fullStr The subtle nuances of intranasal corticosteroids
title_full_unstemmed The subtle nuances of intranasal corticosteroids
title_short The subtle nuances of intranasal corticosteroids
title_sort subtle nuances of intranasal corticosteroids
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968222/
https://www.ncbi.nlm.nih.gov/pubmed/33731223
http://dx.doi.org/10.1186/s40463-020-00480-z
work_keys_str_mv AT fowlerjames thesubtlenuancesofintranasalcorticosteroids
AT rotenbergbrianw thesubtlenuancesofintranasalcorticosteroids
AT sowerbyleighj thesubtlenuancesofintranasalcorticosteroids
AT fowlerjames subtlenuancesofintranasalcorticosteroids
AT rotenbergbrianw subtlenuancesofintranasalcorticosteroids
AT sowerbyleighj subtlenuancesofintranasalcorticosteroids